Efavirenz - ≥98%(HPLC), high purity , Human immunodeficiency virus type 1 reverse transcriptase inhibitor, CAS No.154598-52-4, Human immunodeficiency virus type 1 reverse transcriptase inhibitor

Item Number

E135556

• Synonyms: efavirenz | 154598-52-4 | Sustiva | Stocrin | DMP-266 | DMP 266 | (-)-Efavirenz | EFV | (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one | L-743726 | Viraday | Efavirenz teva | (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)
• Specifications & Purity: Moligand™, ≥98%(HPLC)
• Biochemical and Physiological Mechanisms: Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI). It is an anti-HIV drug, commonly used in combination therapy for AIDs treatment. It is part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency
• Storage Temp: Store at -20°C
• Shipped In: Ice chest + Ice pads
• Grade: Moligand™
• Action Type: INHIBITOR
• Mechanism of action: Human immunodeficiency virus type 1 reverse transcriptase inhibitor
• Note: Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one month. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour. Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.

Product Description

Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI).